美国心脏骤停后神经预后检测的匮乏
该回顾性队列研究利用Optum去标识化电子健康记录数据集(2010—2021年),纳入非创伤性心脏骤停复苏后住院死亡患者34,585例,量化指南推荐的神经预后诊断检测(头颅CT、脑电图、体感诱发电位、脑MRI或神经科评估)的频率与时机。结果仅3,245例(9%)接受至少一项神经诊断检测,1,708例(5%)接受神经科评估,3,004例(9%)接受CT成像,852例(2%)接受至少两种诊断模式;中位住院时间0天[0-1]天,仅16%的死亡发生在第3天或之后。作者认为,若在前瞻性队列中验证,更好的指南依从性和更频繁的多模式神经预后评估可改善心脏骤停后护理质量。
要点
- 34,585例心脏骤停复苏后住院死亡患者中,仅3,245例(9%)接受至少一项神经诊断检测。
- 仅1,708例(5%)接受神经科评估,852例(2%)接受至少两种诊断模式。
- 最常进行的神经诊断检测为CT成像,共3,004例(9%)。
- 中位住院时间0天[0-1]天,仅16%的死亡发生在第3天或之后。
- 作者认为,若在前瞻性队列中验证,更好的指南依从性和更频繁的多模式神经预后评估可改善心脏骤停后护理质量。
适用人群与场景
- 纳入:非创伤性心脏骤停复苏后住院死亡患者。
- 数据来源:Optum®去标识化电子健康记录数据集,2010至2021年。
研究设计与关键结果
- 研究类型:回顾性队列研究,使用Optum®去标识化电子健康记录数据集(2010—2021年)。
- 样本量:纳入34,585例非创伤性心脏骤停复苏后住院死亡患者;中位年龄66岁[四分位距53-79],13,609例(39%)为女性。
- 中位住院时间0天[0-1]天,仅16%的死亡发生在第3天或之后。
- 仅3,245例(9%)接受至少一项神经诊断检测,仅1,708例(5%)接受神经科评估。
- 最常进行的神经诊断检测为CT成像,共3,004例(9%)。
- 仅852例(2%)接受至少两种诊断模式。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,若在前瞻性队列中验证,更好的指南依从性和更频繁的多模式神经预后评估可改善心脏骤停后护理质量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Withdrawal of life-sustaining therapies for perceived poor neurological prognosis is the most common cause of death for patients hospitalized after resuscitation from cardiac arrest. Accurate neuroprognostication is challenging and high stakes, so guidelines recommend multimodality testing. We quantified the frequency and timing with which guideline recommended diagnostics were acquired prior to in-hospital death after cardiac arrest.
METHODS: We performed a retrospective cohort study using the Optum® deidentified Electronic Health Record dataset for 2010 to 2021. We included in-hospital decedents admitted after resuscitation from non-traumatic cardiac arrest. We quantified the number of decedents who underwent head computed tomographic imaging, electroencephalography, somatosensory evoked potentials, brain magnetic resonance imaging, or evaluation by a neurologist, as well as the timing of these tests.
RESULTS: Of 34,585 included patients, median age was 66 [interquartile range 53 - 79] years and 13,609 (39%) were female. Median hospital length of stay was 0 days [0-1] days, and only 16% of deaths occurred on or after day three. Only 3,245 patients (9%) had at least one neurodiagnostic test acquired and only 1,708 (5%) were evaluated by a neurologist. The most common neurological diagnostic test to be obtained was CT imaging, acquired in 3,004 (9%) of the overall cohort. Only 852 patients (2%) of patients had at least two diagnostic modalities obtained.
DISCUSSION: In this retrospective cohort, we found few patients hospitalized after out-of-hospital cardiac arrest underwent guideline-recommended prognostic testing. If validated in prospective cohorts with more granular clinical information, better guideline adherence and more frequent use of multimodality neuroprognostication offer an opportunity to improve quality of post-arrest care.
参考来源
- Elmer J, Steinberg A, Callaway CW, et al. Paucity of neuroprognostic testing after cardiac arrest in the United States. Resuscitation. 2023. PMID: 36924822. doi:10.1016/j.resuscitation.2023.109762
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。